LeClair Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
+17,254
New +$2.02M 1.15% 26
2026
Q1
Sell
-17,132
Closed -$1.8M 158
2025
Q4
$1.8M Buy
17,132
+160
+0.9% +$15K 1.05% 29
2025
Q3
$1.42M Sell
16,972
-148
-0.9% -$12.2K 0.89% 26
2025
Q2
$1.36M Sell
17,120
-352
-2% -$28K 0.92% 27
2025
Q1
$1.57M Buy
17,472
+109
+0.6% +$10.2K 1.13% 21
2024
Q4
$1.73M Buy
+17,363
New +$1.79M 1.15% 22

Other funds holding MRK

LeClair Wealth Partners's MRK Position: Q2 2026 in Review

LeClair Wealth Partners opened a new position in Merck (MRK) in Q2 2026: 17,254 shares worth $2.22M. The stake represents 1.15% of the portfolio and ranks #26 among its holdings. This is a return to the name: LeClair Wealth Partners previously reported a position in MRK as recently as Q4 2025.

LeClair Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • LeClair Wealth Partners held 17,254 shares of Merck worth $2.22M as of Q2 2026.
  • Merck was a new LeClair Wealth Partners position in Q2 2026.
  • Merck made up 1.15% of LeClair Wealth Partners's portfolio in Q2 2026, its #26 holding.
  • LeClair Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.